Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study.

Draaisma K, Chatzipli A, Taphoorn M, Kerkhof M, Weyerbrock A, Sanson M, Hoeben A, Lukacova S, Lombardi G, Leenstra S, Hanse M, Fleischeuer R, Watts C, McAbee J, Angelopoulos N, Gorlia T, Golfinopoulos V, Kros JM, Verhaak RGW, Bours V, van den Bent MJ, McDermott U, Robe PA, French PJ.

J Clin Oncol. 2020 Jan 1;38(1):81-99. doi: 10.1200/JCO.19.00367. Epub 2019 Nov 19.

PMID:
31743054
2.

Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates.

Berendsen S, van Bodegraven E, Seute T, Spliet WGM, Geurts M, Hendrikse J, Schoysman L, Huiszoon WB, Varkila M, Rouss S, Bell EH, Kroonen J, Chakravarti A, Bours V, Snijders TJ, Robe PA.

PLoS One. 2019 Oct 11;14(10):e0222717. doi: 10.1371/journal.pone.0222717. eCollection 2019.

3.

[Study of cancer risks associated with Lynch syndrome in the Liège region].

Lion L, Leclercq P, Plomteux O, Bours V.

Rev Med Liege. 2019 Sep;74(9):479-483. French.

PMID:
31486319
4.

[(S)un (M)ay (A)rise on SMA : the hope of a region without spinal muscular atrophy].

Boemer F, Caberg JH, Dideberg V, Beckers P, Marie S, Marcelis L, Bours V, Dangouloff T, Servais L.

Rev Med Liege. 2019 Sep;74(9):461-464. French.

PMID:
31486315
5.

Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy.

Onesti CE, Boemer F, Josse C, Leduc S, Bours V, Jerusalem G.

J Transl Med. 2019 Jul 23;17(1):239. doi: 10.1186/s12967-019-1984-2.

6.

VPS51 biallelic variants cause microcephaly with brain malformations: A confirmatory report.

Uwineza A, Caberg JH, Hitayezu J, Wenric S, Mutesa L, Vial Y, Drunat S, Passemard S, Verloes A, El Ghouzzi V, Bours V.

Eur J Med Genet. 2019 Aug;62(8):103704. doi: 10.1016/j.ejmg.2019.103704. Epub 2019 Jun 14.

PMID:
31207318
7.

Newborn screening for SMA in Southern Belgium.

Boemer F, Caberg JH, Dideberg V, Dardenne D, Bours V, Hiligsmann M, Dangouloff T, Servais L.

Neuromuscul Disord. 2019 May;29(5):343-349. doi: 10.1016/j.nmd.2019.02.003. Epub 2019 Feb 15.

PMID:
31030938
8.

[Hereditary diffuse gastric cancer : case serie of 8 patients from a single family and literature review].

Jadot V, Segers K, Bours V, Kohnen L, Honoré P, Martin M, De Flines J, Mutijima E, Leclercq P.

Rev Med Liege. 2019 Mar;74(3):134-138. Review. French.

PMID:
30897312
9.

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center.

Daly A, Cano DA, Venegas E, Petrossians P, Dios E, Castermans E, Flores-Martínez A, Bours V, Beckers A, Soto A.

Endocr Connect. 2019 Mar 1. pii: EC-19-0027.R3. doi: 10.1530/EC-19-0027. [Epub ahead of print]

10.

Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma.

Berendsen S, Spliet WGM, Geurts M, Van Hecke W, Seute T, Snijders TJ, Bours V, Bell EH, Chakravarti A, Robe PA.

Cancers (Basel). 2019 Jan 4;11(1). pii: E41. doi: 10.3390/cancers11010041.

11.

Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment.

Onesti CE, Josse C, Poncin A, Frères P, Poulet C, Bours V, Jerusalem G.

Oncotarget. 2018 Sep 14;9(72):33719-33733. doi: 10.18632/oncotarget.26120. eCollection 2018 Sep 14.

12.

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease.

Lenglet M, Robriquet F, Schwarz K, Camps C, Couturier A, Hoogewijs D, Buffet A, Knight SJL, Gad S, Couvé S, Chesnel F, Pacault M, Lindenbaum P, Job S, Dumont S, Besnard T, Cornec M, Dreau H, Pentony M, Kvikstad E, Deveaux S, Burnichon N, Ferlicot S, Vilaine M, Mazzella JM, Airaud F, Garrec C, Heidet L, Irtan S, Mantadakis E, Bouchireb K, Debatin KM, Redon R, Bezieau S, Bressac-de Paillerets B, Teh BT, Girodon F, Randi ML, Putti MC, Bours V, Van Wijk R, Göthert JR, Kattamis A, Janin N, Bento C, Taylor JC, Arlot-Bonnemains Y, Richard S, Gimenez-Roqueplo AP, Cario H, Gardie B.

Blood. 2018 Aug 2;132(5):469-483. doi: 10.1182/blood-2018-03-838235. Epub 2018 Jun 11.

13.

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.

Herfs M, Roncarati P, Koopmansch B, Peulen O, Bruyere D, Lebeau A, Hendrick E, Hubert P, Poncin A, Penny W, Piazzon N, Monnien F, Guenat D, Mougin C, Prétet JL, Vuitton L, Segers K, Lambert F, Bours V, de Leval L, Valmary-Degano S, Quick CM, Crum CP, Delvenne P.

Br J Cancer. 2018 May;118(10):1302-1312. doi: 10.1038/s41416-018-0049-2. Epub 2018 Apr 27.

14.

Genetic assessment and folate receptor autoantibodies in infantile-onset cerebral folate deficiency (CFD) syndrome.

Ramaekers VT, Segers K, Sequeira JM, Koenig M, Van Maldergem L, Bours V, Kornak U, Quadros EV.

Mol Genet Metab. 2018 May;124(1):87-93. doi: 10.1016/j.ymgme.2018.03.001. Epub 2018 Mar 3.

PMID:
29661558
15.

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

Costanza B, Turtoi A, Bellahcène A, Hirano T, Peulen O, Blomme A, Hennequière V, Mutijima E, Boniver J, Meuwis MA, Josse C, Koopmansch B, Segers K, Yokobori T, Fahmy K, Thiry M, Coimbra C, Garbacki N, Colige A, Baiwir D, Bours V, Louis E, Detry O, Delvenne P, Nishiyama M, Castronovo V.

Oncotarget. 2018 Jan 31;9(12):10665-10680. doi: 10.18632/oncotarget.24366. eCollection 2018 Feb 13.

16.

Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions.

Daly AF, Castermans E, Oudijk L, Guitelman MA, Beckers P, Potorac I, Neggers SJCMM, Sacre N, van der Lely AJ, Bours V, de Herder WW, Beckers A.

Endocr Relat Cancer. 2018 May;25(5):L37-L42. doi: 10.1530/ERC-18-0065. Epub 2018 Mar 13. No abstract available.

17.

Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients.

Frères P, Bouznad N, Servais L, Josse C, Wenric S, Poncin A, Thiry J, Moonen M, Oury C, Lancellotti P, Bours V, Jerusalem G.

BMC Cancer. 2018 Jan 29;18(1):102. doi: 10.1186/s12885-018-4015-4.

18.

Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers.

Latgé G, Poulet C, Bours V, Josse C, Jerusalem G.

Int J Mol Sci. 2018 Jan 2;19(1). pii: E123. doi: 10.3390/ijms19010123. Review.

19.

A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases.

Boemer F, Fasquelle C, d'Otreppe S, Josse C, Dideberg V, Segers K, Guissard V, Capraro V, Debray FG, Bours V.

Sci Rep. 2017 Dec 15;7(1):17641. doi: 10.1038/s41598-017-18038-x.

20.

Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer.

Wenric S, ElGuendi S, Caberg JH, Bezzaou W, Fasquelle C, Charloteaux B, Karim L, Hennuy B, Frères P, Collignon J, Boukerroucha M, Schroeder H, Olivier F, Jossa V, Jerusalem G, Josse C, Bours V.

Sci Rep. 2017 Dec 12;7(1):17452. doi: 10.1038/s41598-017-17811-2.

21.

Innovative PCR without DNA extraction for African sickle cell disease diagnosis.

Detemmerman L, Olivier S, Bours V, Boemer F.

Hematology. 2018 Apr;23(3):181-186. doi: 10.1080/10245332.2017.1371470. Epub 2017 Sep 20.

PMID:
28929945
22.

[A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update].

Valdes-Socin H, Palmeira L, Burlacu MC, Daly AF, Bours V, Beckers A.

Rev Med Liege. 2016 Dec;71(12):557-561. Review. French.

23.

[Cancer therapy-induced cardiotoxicity].

Frères P, Poncin A, Moonen M, Josse C, Oury C, Bours V, Lancellotti P, Jerusalem G.

Rev Med Liege. 2016 Sep;71(9):382-387. Review. French.

24.

A novel SMAD3 mutation caused multiple aneurysms in a patient without osteoarthritis symptoms.

Courtois A, Coppieters W, Bours V, Defraigne JO, Colige A, Sakalihasan N.

Eur J Med Genet. 2017 Apr;60(4):228-231. doi: 10.1016/j.ejmg.2017.02.001. Epub 2017 Feb 7.

PMID:
28185953
25.
26.

Exome copy number variation detection: Use of a pool of unrelated healthy tissue as reference sample.

Wenric S, Sticca T, Caberg JH, Josse C, Fasquelle C, Herens C, Jamar M, Max S, Gothot A, Caers J, Bours V.

Genet Epidemiol. 2017 Jan;41(1):35-40. doi: 10.1002/gepi.22019. Epub 2016 Nov 10.

27.

IκBζ: an emerging player in cancer.

Willems M, Dubois N, Musumeci L, Bours V, Robe PA.

Oncotarget. 2016 Oct 4;7(40):66310-66322. doi: 10.18632/oncotarget.11624. Review.

28.

MicroRNAs and Inflammation in Colorectal Cancer.

Josse C, Bours V.

Adv Exp Med Biol. 2016;937:53-69. doi: 10.1007/978-3-319-42059-2_3. Review.

PMID:
27573894
29.

Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexity.

Sticca T, Caberg JH, Wenric S, Poulet C, Herens C, Jamar M, Josse C, El Guendi S, Max S, Beguin Y, Gothot A, Caers J, Bours V.

Genes Chromosomes Cancer. 2017 Jan;56(1):18-27. doi: 10.1002/gcc.22397. Epub 2016 Aug 18.

30.

CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone.

Goffart N, Lombard A, Lallemand F, Kroonen J, Nassen J, Di Valentin E, Berendsen S, Dedobbeleer M, Willems E, Robe P, Bours V, Martin D, Martinive P, Maquet P, Rogister B.

Neuro Oncol. 2017 Jan;19(1):66-77. doi: 10.1093/neuonc/now136. Epub 2016 Jul 1.

31.

Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.

Mangupli R, Rostomyan L, Castermans E, Caberg JH, Camperos P, Krivoy J, Cuauro E, Bours V, Daly AF, Beckers A.

Pituitary. 2016 Oct;19(5):507-14. doi: 10.1007/s11102-016-0732-3.

PMID:
27287035
32.

Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential.

Dubois N, Willems M, Nguyen-Khac MT, Kroonen J, Goffart N, Deprez M, Bours V, Robe PA.

Int J Oncol. 2016 Jun;48(6):2445-52. doi: 10.3892/ijo.2016.3490. Epub 2016 Apr 18.

PMID:
27098015
33.

Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation.

Corman V, Potorac I, Manto F, Dassy S, Segers K, Thiry A, Bours V, Daly AF, Beckers A.

Endocr Relat Cancer. 2016 May;23(5):391-7. doi: 10.1530/ERC-16-0057. Epub 2016 Mar 21.

34.

Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects.

Daly AF, Yuan B, Fina F, Caberg JH, Trivellin G, Rostomyan L, de Herder WW, Naves LA, Metzger D, Cuny T, Rabl W, Shah N, Jaffrain-Rea ML, Zatelli MC, Faucz FR, Castermans E, Nanni-Metellus I, Lodish M, Muhammad A, Palmeira L, Potorac I, Mantovani G, Neggers SJ, Klein M, Barlier A, Liu P, Ouafik L, Bours V, Lupski JR, Stratakis CA, Beckers A.

Endocr Relat Cancer. 2016 Apr;23(4):221-33. doi: 10.1530/ERC-16-0082. Epub 2016 Mar 2.

35.

GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency.

Castinetti F, Daly AF, Stratakis CA, Caberg JH, Castermans E, Trivellin G, Rostomyan L, Saveanu A, Jullien N, Reynaud R, Barlier A, Bours V, Brue T, Beckers A.

Horm Metab Res. 2016 Jun;48(6):389-93. doi: 10.1055/s-0042-100733. Epub 2016 Jan 21.

36.

Circulating microRNA-based screening tool for breast cancer.

Frères P, Wenric S, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V, Josse C, Jerusalem G.

Oncotarget. 2016 Feb 2;7(5):5416-28. doi: 10.18632/oncotarget.6786.

37.

GHRH excess and blockade in X-LAG syndrome.

Daly AF, Lysy PA, Desfilles C, Rostomyan L, Mohamed A, Caberg JH, Raverot V, Castermans E, Marbaix E, Maiter D, Brunelle C, Trivellin G, Stratakis CA, Bours V, Raftopoulos C, Beauloye V, Barlier A, Beckers A.

Endocr Relat Cancer. 2016 Mar;23(3):161-70. doi: 10.1530/ERC-15-0478. Epub 2015 Dec 15.

38.

Cytogenetic Studies of Rwandan Pediatric Patients Presenting with Global Developmental Delay, Intellectual Disability and/or Multiple Congenital Anomalies.

Uwineza A, Hitayezu J, Jamar M, Caberg JH, Murorunkwere S, Janvier N, Bours V, Mutesa L.

J Trop Pediatr. 2016 Feb;62(1):38-45. doi: 10.1093/tropej/fmv065. Epub 2015 Oct 27.

39.

Identification and frequencies of cystic fibrosis mutations in central Argentina.

Pepermans X, Mellado S, Chialina S, Wagener M, Gallardo L, Lande H, Bordino W, Baran D, Bours V, Leal T.

Clin Biochem. 2016 Jan;49(1-2):154-60. doi: 10.1016/j.clinbiochem.2015.10.007. Epub 2015 Oct 21.

PMID:
26500004
40.

Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers.

Boukerroucha M, Josse C, ElGuendi S, Boujemla B, Frères P, Marée R, Wenric S, Segers K, Collignon J, Jerusalem G, Bours V.

BMC Cancer. 2015 Oct 21;15:755. doi: 10.1186/s12885-015-1740-9.

41.

Prognostic relevance of epilepsy at presentation in glioblastoma patients.

Berendsen S, Varkila M, Kroonen J, Seute T, Snijders TJ, Kauw F, Spliet WG, Willems M, Poulet C, Broekman ML, Bours V, Robe PA.

Neuro Oncol. 2016 May;18(5):700-6. doi: 10.1093/neuonc/nov238. Epub 2015 Sep 29.

42.

[BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].

Jerusalem G, Collignon J, Josse C, Schroeder H, Rorive A, Frères P, Lambert F, Koopmansch B, Poncin A, Bours V.

Rev Med Liege. 2015 May-Jun;70(5-6):269-76. Review. French.

43.

[PHARMACOGENOMICS AND PERSONALIZED MEDICINE: TOWARDS A SYSTEMATIC GENOMIC SCREENING?].

Dideberg V, Segers K, Koopmansch B, Lambert F, Bours V.

Rev Med Liege. 2015 May-Jun;70(5-6):251-6. French.

44.

Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, Lecumberri B, Trivellin G, Salvatori R, Moraitis AG, Holdaway I, Kranenburg-van Klaveren DJ, Chiara Zatelli M, Palacios N, Nozieres C, Zacharin M, Ebeling T, Ojaniemi M, Rozhinskaya L, Verrua E, Jaffrain-Rea ML, Filipponi S, Gusakova D, Pronin V, Bertherat J, Belaya Z, Ilovayskaya I, Sahnoun-Fathallah M, Sievers C, Stalla GK, Castermans E, Caberg JH, Sorkina E, Auriemma RS, Mittal S, Kareva M, Lysy PA, Emy P, De Menis E, Choong CS, Mantovani G, Bours V, De Herder W, Brue T, Barlier A, Neggers SJ, Zacharieva S, Chanson P, Shah NS, Stratakis CA, Naves LA, Beckers A.

Endocr Relat Cancer. 2015 Oct;22(5):745-57. doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17.

45.

Mutation of the iron-sulfur cluster assembly gene IBA57 causes fatal infantile leukodystrophy.

Debray FG, Stümpfig C, Vanlander AV, Dideberg V, Josse C, Caberg JH, Boemer F, Bours V, Stevens R, Seneca S, Smet J, Lill R, van Coster R.

J Inherit Metab Dis. 2015 Nov;38(6):1147-53. doi: 10.1007/s10545-015-9857-1. Epub 2015 May 14.

PMID:
25971455
46.

BRCA1 germline mutation and glioblastoma development: report of cases.

Boukerroucha M, Josse C, Segers K, El-Guendi S, Frères P, Jerusalem G, Bours V.

BMC Cancer. 2015 Mar 26;15:181. doi: 10.1186/s12885-015-1205-1.

47.

Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer.

Bovy N, Blomme B, Frères P, Dederen S, Nivelles O, Lion M, Carnet O, Martial JA, Noël A, Thiry M, Jérusalem G, Josse C, Bours V, Tabruyn SP, Struman I.

Oncotarget. 2015 Apr 30;6(12):10253-66.

48.

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis.

Hanssen O, Castermans E, Bovy C, Weekers L, Erpicum P, Dubois B, Bours V, Krzesinski JM, Jouret F.

Clin Kidney J. 2014 Jun;7(3):282-5. doi: 10.1093/ckj/sfu019. Epub 2014 Mar 16.

49.

X-linked acrogigantism syndrome: clinical profile and therapeutic responses.

Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR, Yuan B, Choong CS, Caberg JH, Verrua E, Naves LA, Cheetham TD, Young J, Lysy PA, Petrossians P, Cotterill A, Shah NS, Metzger D, Castermans E, Ambrosio MR, Villa C, Strebkova N, Mazerkina N, Gaillard S, Barra GB, Casulari LA, Neggers SJ, Salvatori R, Jaffrain-Rea ML, Zacharin M, Santamaria BL, Zacharieva S, Lim EM, Mantovani G, Zatelli MC, Collins MT, Bonneville JF, Quezado M, Chittiboina P, Oldfield EH, Bours V, Liu P, W de Herder W, Pellegata N, Lupski JR, Daly AF, Stratakis CA.

Endocr Relat Cancer. 2015 Jun;22(3):353-67. doi: 10.1530/ERC-15-0038. Epub 2015 Feb 24.

50.

Modulating effect of COMT Val(158)Met polymorphism on interference resolution during a working memory task.

Jaspar M, Dideberg V, Bours V, Maquet P, Collette F.

Brain Cogn. 2015 Apr;95:7-18. doi: 10.1016/j.bandc.2015.01.013. Epub 2015 Feb 12.

Supplemental Content

Support Center